• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form EFFECT filed by Myovant Sciences Ltd.

    3/17/23 12:15:10 AM ET
    $MYOV
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $MYOV alert in real time by email
    Notice of Effectiveness
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    Notice of Effectiveness
    Effectiveness Date: March 16, 2023
    Accession Number: 0001140361-23-011050
    Submission Type: POS AM
    CIK: 0001679082
    Company Name: Myovant Sciences Ltd.
    File Number: 333-221526
    Get the next $MYOV alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $MYOV

    DatePrice TargetRatingAnalyst
    10/26/2022Outperform → In-line
    Evercore ISI
    8/9/2022$12.00 → $23.00Mkt Perform → Outperform
    SVB Leerink
    2/16/2022$21.00 → $19.00Market Perform
    SVB Leerink
    1/5/2022$23.00 → $21.00Market Perform
    SVB Leerink
    10/27/2021$24.00 → $23.00Market Perform
    SVB Leerink
    9/9/2021$24.00Market Perform
    SVB Leerink
    8/20/2021$18.00Neutral
    Goldman
    More analyst ratings